Deficiency in the collectin mannose-binding lectin (MBL) increases the risk for pulmonary and systemic infections and its complications in children and adults. The aim of this prospective cohort study was to determine the genetic association of sequence variations within the MBL gene with systemic infections and pulmonary short-and long-term complications in preterm infants below 32 weeks gestational age (GA). Three single-nucleotide polymorphisms (SNPs) in the coding region and one SNP in the promotor region of MBL2 were genotyped by direct sequencing and with sequence-specific probes in 284 newborn infants o32 weeks GA. Clinical variables were comprehensively monitored. An association was found between two SNPs and the development of bronchopulmonary dysplasia (BPD), defined as persistent oxygen requirement at 36 weeks postmenstrual age, adjusting for covariates GA, grade of respiratory distress syndrome and days on mechanical ventilation (rs1800450 (exon 1 at codon 54, B variant): odds ratio dominant model (OR) ¼ 3.59, 95% confidence interval (CI) ¼ 1.62-7.98; rs7096206 (À221, X variant): OR ¼ 2.40, 95% CI ¼ 1. 16-4.96). Haplotype analyses confirmed the association to BPD, and a single haplotype (frequency 56%) including all SNPs in their wild-type form showed a negative association with the development of BPD. We detected no association between the MBL gene variations and the development of early-onset infections or further pulmonary complications. Frequent variants of the MBL gene, leading to low MBL concentrations, are associated with the diagnosis of BPD in preterm infants. This provides a basis for potential therapeutic options and further genetic and proteomic analysis of the function of MBL in the resistance against pulmonary long-term complications in preterm infants.
Introduction
Mannose-binding lectin (MBL) is a member of the collagenous subfamily of calcium-dependent lectins (collectins) that includes pulmonary surfactant protein-A and the serum protein surfactant protein-D. Strong indications prove that MBL plays an important role in the humoral innate immune system. 1 With multiple carbohydrate-recognition domains, MBL is able to bind to sugar groups displayed on the surfaces of various pathogens and thereby provide firstline defense. MBL also activates the complement system through a distinctive third pathway, independent of both antibody and the C1 complex. 2 A number of studies investigated the large interindividual variation in serum MBL levels, and circulating MBL concentrations as well as functional activity of the protein were found to be correlated with common genetic variants in the MBL2 gene. 3 There are two human MBL genes, but only MBL2 encodes a protein product; MBL1 is a pseudogene. The functional MBL2 gene is located on chromosome 10 (q11.2-q21) and comprises four exons. Three single-nucleotide polymorphisms (SNPs) in codons 52, 54 and 57 (D, B and C variants, respectively, with variant A indicating the wild-type and the three variant alleles collectively termed O) of exon 1 are believed to impair oligomerization and lead to a functional deficiency of MBL. 1, 4 The B and C mutations result in the replacement of axial glycines in the triple helix by dicarboxylic acids. 5 In contrast, the D mutation results in the replacement of an amino acid (arginine with cysteine) hindering higher oligomer formation. 6 Several polymorphisms have also been reported in the promoter region of the gene. Three promoter polymorphisms (H/L, X/Y and P/Q at codons À550, À221 and þ 4, respectively) are in linkage disequilibrium with the exon 1 SNPs. There is a strong association between MBL SNPs and haplotypes and the serum level of the MBL protein.
Numerous disease association studies suggested an important role for MBL in relation to the acquisition or the clinical course of infectious diseases in children and adults. 3, [7] [8] [9] [10] Especially in immunocompromised individuals, MBL deficiency appears to exert effects on susceptibility and severity of infectious diseases. [11] [12] [13] [14] [15] [16] Because their adaptive immunity has not yet been developed, MBL is particularly important in neonates in whom immune defense depends on maternal antibodies and innate defense mechanisms. The ability to respond effectively to infectious hazards clearly determines acute and long-term outcome especially in preterm infants. [17] [18] [19] Thus, several studies revealed pre-and postnatal infections to contribute to the development of chronic lung disease in preterm infants, 18, [20] [21] [22] which mainly determines morbidity and mortality during the first year of life in this patient cohort. Bronchopulmonary dysplasia (BPD) is histologically characterized by decreased alveolar septation resulting in large saccular airspaces, representing a rupture of pulmonary development from the saccular to the alveolar stage. 23 The persistence of inflammatory processes, partially triggered by early onset or nosocomial infections as well as ventilatorinduced lung injury, leads to impairment of alveolarization and vascularization. [24] [25] [26] [27] Based on the fact that MBL concentrations in umbilical cord blood were found to be predictive for the development of infections in neonates and early childhood 11, 28, 29 and the knowledge that polymorphisms of the MBL gene profoundly influences levels of the protein, we hypothesized that genetic variation of the MBL gene could be associated with the clinical outcome of preterm infants o32 GA.
The aim of this study therefore was to investigate whether genetic variation of the MBL gene is associated with an increase in pulmonary and systemic early-onset infections or with the risk of development of pulmonary complications, that is respiratory distress syndrome (RDS) and BPD in very immature preterm infants p32 weeks gestational age (GA).
Results
Patients' baseline characteristics are given in Table 1 The genotype frequencies for both the exon 1 polymorphisms and the promotor polymorphisms were in Hardy-Weinberg equilibrium, indicating the state of random assortment.
Association of MBL polymorphism with pulmonary morbidity Logistic regression analyses indicated an effect of GA, grade of RDS and days on mechanical ventilation on pulmonary morbidity, that is, moderate or severe BPD as diagnosed at 36 weeks GA. Independent of the identified covariates, there was a significant association between one SNP in exon 1 (rs1800450, codon 54) and in the promotor region (rs7096206, À221) and the presence of BPD at 36 weeks GA in the study cohort. Analyses showed that, under a model of dominant inheritance, carriers of the A allele in codon 54 (B variant; coding for aspargine) had a higher prevalence of BPD compared to those who were homozygous for the G allele (odds ratio (OR) ¼ 3.59, 95% confidence interval (CI) ¼ 1.62-7.98, adjusted two-sided P ¼ 0.0068). Furthermore, carriers of the C allele at position À221 (X variant) also revealed a higher prevalence of BPD compared to those who were homozygous for the G allele (OR ¼ 2.40, 95% CI ¼ 1.16-4.96, adjusted two-sided P ¼ 0.0372). Differences in the prevalence of BPD for carriers of MBL polymorphisms are shown in Table 2 .
Similar results were seen when the investigated polymorphisms were analyzed to the common scientific notation including the D, B, C and A allele variants (Table 3) .
There was neither association of the polymorphisms investigated with the presence of early-onset or nosocomial systemic or pulmonary infections until discharge nor acute pulmonary complications or the presence of RDS or the development of air leak, that is pneumothorax (Table 4) .
Association of MBL haplotypes with pulmonary morbidity Four putative human MBL haplotypes with a frequency of at least 1% were estimated, which possessed a cumulative frequency of 98.9% (Table 5 ).
The association of putative MBL haplotype estimates with the qualitative phenotype (presence of BPD) was calculated using a score test assuming ordinally scaled values. The association of putative MBL haplotypes with BPD, independent of the factors GA and days on mechanical ventilation, differed across the estimated haplotypes (P ¼ 0.0087).
The MBL haplotypes MBL*03 (YB) (frequency ¼ 14.32%) and MBL*02 (XA; frequency ¼ 21.38%) revealed positive associations with the diagnosis of BPD (P ¼ 0.0048 and 0.0216, respectively; Table 5 ). In contrast, the wild-type haplotype MBL*01 (YA; frequency ¼ 55.97%) showed a negative association with the development of BPD (Po0.0001; Table 5 ). Association between MBL and pulmonary morbidity in preterms A Hilgendorff et al Similar results were seen when the investigated haplotypes were analyzed according to the common scientific notation (Table 6 ).
Discussion
The collectins, humoral lectins of the innate immune defense, have been shown to be primarily involved in the elimination of microorganisms and the orchestration of the following immune response to microbial challenge, protecting against neonatal infections before the development of an appropriate adaptive immune response. [29] [30] [31] Plasma levels and functional activity of the collectins are known to be determined by polymorphisms in exon 1 and in the promotor region of the MBL2 gene, and thus a genetic susceptibility to the development of severe infections has been suggested as genetic variants associated with low MBL concentrations revealed a clinical phenotype. 3, [7] [8] [9] [10] Preterm infants, known to exhibit a markedly increased risk for the development of severe infections, may critically depend on their innate immune response, as the presence of early-onset and nosocomial infections mainly determines acute and long-term morbidity and mortality in this population, especially regarding the development of neurological and pulmonary impairment. [17] [18] [19] Especially, the development of chronic lung disease in preterm infants is known to be triggered by infectious complications and ongoing inflammatory processes. 18, [20] [21] [22] The aim of the present study therefore was to investigate whether genetic variation within the MBL gene is associated with alterations of acute and long-term pulmonary morbidity in preterm infants. We detected an association of the B-variant allele in the MBL coding region (rs1800450, exon 1 at codon 54) with the diagnosis of BPD at 36 weeks GA (moderate, severe) in a population of preterm infants o32 weeks GA. Patients being carriers for the minor allele were found to have an increased rate of BPD compared to the population being homozygous for the wild-type allele. The SNP in codon 54 of exon 1 of the gene replaces glycine in the expressed protein with aspargine. It is believed that the secondary structure of the collagenous triple helix is distorted when an axial glycine is replaced by another amino acid. In individuals homozygous for this variant, there is evidence for small amounts of protein with a molecular weight close to 100 kDa, but there is relatively little stable assembly of higher order oligomers and lack of complement activation. Serum levels were shown to be reduced to one fourth in the presence of this variant (for review see Turner 1 and Turner and Hamvas 4 ). Association between MBL and pulmonary morbidity in preterms A Hilgendorff et al
In addition, we found an association of BPD with the X-variant allele in the promotor region (rs7096206; À221), which has been shown to be associated with reduced MBL serum levels (for review see Turner  1 and Turner  and Hamvas   4 ). Thus, two separate frequent SNPs as well as the consecutively defined haplotypes revealed a positive association in the presence of BPD at 36 weeks GA in preterm infants, while the haplotype MBL*01 (YA), which includes the frequent forms of the alleles, revealed a negative association with the presence of BPD. We conclude that this haplotype may have a protective effect of developing BPD at 36 weeks GA.
Recent publications indicated a strong association between the development of sepsis and genetic polymorphisms in the exon 1 region of the MBL gene. 32 The association of this genetic variation with the development of chronic lung disease in preterm infants may thus be caused by lower MBL serum levels and malfunction of the protein. The persistence of inflammatory processes in the premature lung may lead to severe functional and structural changes resulting in the typical histological pattern of BPD as has been shown previously. 24, 26, 27 Inactivation of surfactant components, activation of elastase activity and impairment of alveolarization and vascularization are part of the initiated pathologic Association between MBL and pulmonary morbidity in preterms A Hilgendorff et al processes. [33] [34] [35] [36] [37] In line with our findings, Gibson et al. 38 have shown previously an association between genetic polymorphisms in the MBL gene at codon 54 and the presence of long-term neurological outcome, that is, cerebral palsy in infants. Furthermore, the potential role of MBL in apoptotic processes has to be discussed in context with our findings. Pro-and antiapoptotic mechanisms are known to play an important role in BPD as shown by experimental and clinical studies. [39] [40] [41] A deficiency in MBL may thus lead to a disturbed balance of the indicated pathways contributing to severe alterations in alveolo-and vasculogenesis as well as fibrotic changes. 42 Furthermore, the complexity of BPD pathogenesis suggests a potential role for different humoral lectins in pulmonary defense mechanisms and modulation of infectious complications as well as local inflammatory processes. Thus, the functional relationship of MBL and other humoral lectins as SP-D and SP-A in the pulmonary innate host defense may reveal new aspects in the pathogenesis of the disease that need to be focussed in further studies. 43, 44 Furthermore, the results of this study need to be validated in further independent samples.
The fact that no association between the development of early-onset or nosocomial infections and the MBL polymorphisms investigated was detected can be explained by the severe immaturity of the immune system in the preterm infants. Thus, the incidence of infections may not be altered significantly in this population, but the duration of the inflammatory process and the severity of the tissue damage may be influenced by an altered innate immune response. Also, we cannot at this point rule out that no further associations were found because of lack of power. Furthermore, there might be other variants in the MBL gene that do not fully capture the linkage disequilibrium structure.
The discovery of frequent haplotypes of the MBL gene associated with BPD in preterm infants provides a basis for further proteomic and genetic analyses of the function of MBL to understand pathophysiological processes and develop therapeutic options for BPD.
Patients and methods

Patients
Two hundred and eighty-four preterm infants below 32 weeks GA (28.772.3 weeks) were enrolled prospectively in the study after parental informed consent was obtained. The study was performed according to the ethical standards of the responsible committee on investigations in human subjects (Declaration of Helsinki).
Basic prenatal and neonatal variables as well as markers of pulmonary and/or infectious complications were defined and documented prospectively (Table 1) . Any administration of antenatal corticosteroids was recorded. Chorioamnionitis was defined as the presence of inflammatory changes of the chorionic plate at macroscopic examination and maternal fever or elevated laboratory signs of infection. 45 Early-onset infections were diagnosed clinically in the first 72 h of life defined as presence of typical clinical signs, for example, respiratory distress and impaired microcirculation as well as increased C-reactive protein concentration and/ or a pathologic ratio of immature to total granulocytes 40.2 as well as pathological white blood cell counts. [46] [47] [48] [49] Early-onset pneumonia was defined according to Sherman et al. 48 with the presence of bacteria in tracheal aspirates combined with clinical and laboratory signs of infection. Nosocomial infections in terms of the abovedefined clinical and laboratory criteria were monitored comprehensively.
RDS was scored radiologically according to Couchard et al. 50 BPD was defined as the need for supplemental oxygen at 28 days postnatally (mild), oxygen requirements below (moderate) or above (severe) 30% at 36 weeks postmenstrual age. 23 
Blood samples
Umbilical cord blood samples were collected immediately off birth in K2-ethylenediaminetetraacetic acid tubes (Sarstedt, Nü mbrecht, Germany). The samples were centrifuged at 800 g for 10 min. Plasma and buffy coat were separated immediately. Plasma was stored in aliquots at À701 C and was defrosted in a 371 C water bath before use. DNA was extracted from peripheral blood leukocytes using a Puregene DNA isolation kit (Gentra Systems, Minneapolis, MN, USA) according to the manufacturer's instructions. DNA was dissolved in DNA hydration solution and stored at 701 C until use.
Genotyping and direct sequencing of MBL sequence variants Genotyping of rs5030737 (codon 52), rs1800450 (codon 54) and rs1800451 (codon 57) was performed by sequencing on an ABI Prism 3100 Genetic Analyzer (Applied Biosystems, Foster City, CA, USA), using an ABI BigDye Terminator DNA Sequencing kit according to the manufacturer's instructions. Sequence alignment and SNP validation were analyzed using SeqScape software (ABI). SNP rs7096206 (À221 G4C) was genotyped using TaqMan PCR with sequence-specific fluorescence-labeled probes (ABI PRISM 7000 Sequence Detection System, TaqMan). Genotyping primers and probes are listed in Table 7 . PCR was carried out in a volume of 15 ml containing 20 ng genomic DNA, forward and reverse primers in final concentrations of 900 nM, fluorescence-labeled, sequence-specific minor groove binders (MGB) probes in final concentrations of 200 nM and MasterMix Buffer (containing polymerase MgCl 2 , dNTPs including dUTP and UNG). PCR was performed in the following steps according to the universal protocol supplied by ABI:
1. Contamination control 501 C for 2 min. 2. Heat activation 951 C for 10 min. 3. Annealing/extension 40 cycles of 951 C for 15 s and 601 C for 1 min. Association between MBL and pulmonary morbidity in preterms A Hilgendorff et al
Fluorescence emission was measured on an ABI PRISM 7000 Sequence Detection System at 601 C. Known DNA samples of each genotype and water samples were used as positive and negative controls for each run, and quality of genotyping was visually inspected by checking intensity plots.
Statistical analyses
To determine whether the investigated genotypes confirmed with the Hardy-Weinberg equilibrium, we used the exact conditional equivalence test proposed by Wellek at the 5% test-level with e ¼ 0.1 51 In the association analyses, logistic regression models were developed to predict the clinical groups with adjustments for gender, GA, chorioamnionitis, administration of antenatal corticosteroids, early-onset and nosocomial infections, RDS and days on mechanical ventilation. To determine whether an association with MBL polymorphisms might depend on previously determined factors, we investigated the association of MBL polymorphisms while controlling for the risk factors that had been identified previously by adding the polymorphisms to the thus obtained logistic regression models. ORs for the additive effect with 95% CI are presented together with two-sided P-values from Wald-type tests.
To account for the multiple testing of four SNPs, nominal P-values were adjusted using the procedure by Simes. 52 Because the three investigated phenotypes are directly dependent as described in the introduction, no additional adjustment was performed.
Frequencies of haplotypes were estimated with the expectation-maximization algorithm. The effect of the estimated haplotype frequencies was analyzed utilizing generalized linear models allowing for ambiguous haplotypes including the covariates identified in the logistic regression model. 53 Furthermore, we combined the genotypes as given by Gordon et al. 32 and tested for frequency differences between the two patient groups using a w 2 test for independence rendering exact twosided P-values. For haplotype prediction, we used the package haplo.stats for R developed by Schaid. 54 
